Stenham Asset Management Ltd / FATE
Stenham Asset Management Ltd’s Fate Therapeutics Inc Position
Does Stenham Asset Management Ltd own Fate Therapeutics Inc (FATE)? Not currently — the last reported position was 33.9K shares worth $3M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2021
Shares
33.9K
% of Portfolio
+1.97%
Quarters Held
1
position exited
Position History FATE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2021 | 33.9K | $3M | +1.97% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stenham Asset Management Ltd’s full portfolio or all institutional holders of FATE.